The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Exploratory analysis of the effect of maintenance rucaparib on postprogression outcomes in patients (pts) with platinum-sensitive recurrent ovarian carcinoma (OC) and updated safety data from the phase 3 study ARIEL3.
 
Robert L. Coleman
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; GamaMabs Pharma; Genentech/Roche; Genmab; NCCN; Oncolytics; OncoMed; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; ImmunoGen; Merck; PharmaMar; Roche; Takeda; Tesaro
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Carol Aghajanian
Consulting or Advisory Role - Clovis Oncology; Clovis Oncology; Clovis Oncology; Immunogen; Mateon Therapeutics; Mateon Therapeutics; Tesaro; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab/Seattle Genetics; ImmunoGen; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro
 
Andrew Peter Dean
Consulting or Advisory Role - Precision Oncology; Shire; Specialised Therapeutics
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Johanne I Weberpals
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie
 
Andrew R. Clamp
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); Lilly (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Giovanni Scambia
No Relationships to Disclose
 
Alexandra Leary
Honoraria - AstraZeneca; Clovis Oncology; Pharmamar; Tesaro
Consulting or Advisory Role - AstraZeneca; Biocad; Clovis Oncology; GamaMabs Pharma; Gritstone Bio; pfizer; Seagen; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genentech (Inst); inivata (Inst); Merus (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Robert W. Holloway
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - AstraZeneca; Bard/Davol; Clovis Oncology; Intuitive Surgical; Tesaro
 
Margarita Amenedo
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology
Speakers' Bureau - AstraZeneca; Lilly; PharmaMar; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Lilly; Roche
 
Peter C.C. Fong
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
 
Jeffrey C. Goh
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Roche
 
David M. O'Malley
Honoraria - Abbvie; Ambry Genetics; AstraZeneca; BioMedical Insights; Clovis Oncology; Genentech/Roche; GOG Foundation; Immunogen; Janssen Oncology; Marker Therapeutics; Myriad Genetics; Novocure; OncLive; OncoQuest; Prime Oncology; Targeted Oncology; Tesaro; Translational Genomics Research Institute
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Genentech/Roche; GOG Foundation; Immunogen; Janssen Oncology; Myriad Genetics; Novocure; OncoQuest; Tesaro; Translational Genomics Research Institute
Research Funding - Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Stem CentRx (Inst); Tesaro (Inst); TRACON Pharma (Inst); VentiRx (Inst)
 
Teresa Cameron
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Lara Maloney
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Jonathan A. Ledermann
Honoraria - AstraZeneca/MedImmune; Roche
Consulting or Advisory Role - Artios; AstraZeneca/MedImmune; Clovis Oncology; Cristal Therapeutics; Merck; Pfizer; Seagen; Tesaro
Speakers' Bureau - Clovis Oncology; Pfizer
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)